Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc.

NASDAQ:ARQT

Overview | Financials
Company Name Arcutis Biotherapeutics, Inc.
Symbol ARQT
Currency USD
Price 15.16
Market Cap 1,798,552,080
Dividend Yield 0%
52-week-range 6.99 - 16.2
Industry Biotechnology
Sector Healthcare
CEO Mr. Todd Franklin Watanabe M.A.
Website https://www.arcutis.com

An error occurred while fetching data.

About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam

Related Stocks

Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc.

AXSM

119.45 USD

LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc.

LMAT

81.52 USD

NeoGenomics, Inc. logo

NeoGenomics, Inc.

NEO

10.23 USD

Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc.

LYEL

0.672 USD

BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc.

BBIO

32.59 USD

Crinetics Pharmaceuticals, Inc. logo

Crinetics Pharmaceuticals, Inc.

CRNX

35.4 USD

Veru Inc. logo

Veru Inc.

VERU

0.492 USD

Financials

Numbers are in millions USD

Numbers are in millions USD